RealSense grabbed $50 million for physical AI; Debenhams deepened AWS partnership; Bonx wants to streamline the European factory and more.

Amazon said Kiro goes beyond specs and hooks for developers and can be expanded with the Model Context Protocol, an ...

AstraZeneca's Calquence hits the mark in the AMPLIFY combination trial in CLL, which could unlock a blockbuster opportunity for the BTK inhibitor.

Current and Historical Performance Performance for Amplify Transformational Data Sharing ETF on Yahoo Finance.